Patents by Inventor Chenmin TIAN

Chenmin TIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220017601
    Abstract: Disclosed in the present disclosure are a TGF-? receptor fusion protein pharmaceutical composition and a use thereof. Specifically, the pharmaceutical composition comprises a TGF-? receptor fusion protein in a sodium citrate buffer, and the TGF-? receptor fusion protein comprises a PD-L1 antibody targeting portion and a TGF-?RII extracellular region. In addition, the pharmaceutical composition may also comprise a sugar and a non-ionic surfactant.
    Type: Application
    Filed: November 8, 2019
    Publication date: January 20, 2022
    Inventors: Chenmin TIAN, Hao LI, Xun LIU
  • Publication number: 20210261663
    Abstract: Disclosed in the present application are a TIM3 antibody pharmaceutical composition and use thereof. In particular, the pharmaceutical composition comprises a TIM3 antibody or antigen-binding fragment thereof in a buffer. In addition, the pharmaceutical composition further comprises a saccharide and a nonionic surfactant. The pharmaceutical composition of the present invention has good stability.
    Type: Application
    Filed: August 27, 2019
    Publication date: August 26, 2021
    Inventors: Chenmin TIAN, Hao LI, Xun LIU, Zhuoxiao CAO
  • Publication number: 20200223941
    Abstract: Provided is a pharmaceutical composition comprising a PCSK9 antibody or an antigen-binding fragment thereof in a histidine buffer. In addition, the pharmaceutical composition may also comprise saccharides and nonionic surfactants.
    Type: Application
    Filed: June 29, 2018
    Publication date: July 16, 2020
    Inventors: Chenmin TIAN, Hao LI, Xun LIU